Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
221.2 CHF | +0.52% | -1.73% | -9.57% |
09:58am | Roche: approval in lung cancer in the United States | CF |
08:48am | Nykode Therapeutics Launches Phase 2 Clinical Trial for Cervical Cancer Vaccine | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.57% | 194B | |
+25.60% | 672B | |
+24.08% | 550B | |
-6.54% | 351B | |
+14.79% | 317B | |
+6.67% | 292B | |
+3.11% | 211B | |
+0.45% | 203B | |
-10.82% | 144B | |
-8.13% | 141B |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- Roche : to Resume Delivery of Self COVID-19 Tests Following Delay